What should I avoid while taking Zitrolid?
Antibiotic medicines can cause diarrhea, which may be a sign of a new infection. If you have diarrhea that is watery or bloody, call your doctor before using anti-diarrhea medicine.
Zitrolid could make you sunburn more easily. Avoid sunlight or tanning beds. Wear protective clothing and use sunscreen (SPF 30 or higher) when you are outdoors.
Zitrolid has been reported to be excreted in breast milk in small amounts. Caution should be exercised when Zitrolid is administered to a nursing woman.
Quantitative methods that require measurement of zone diameters also provide reproducible estimates of the susceptibility of bacteria to antibacterial compounds. One such standardized procedure 2 that has been recommended for use with disks to test the susceptibility of microorganisms to Zitrolid uses the 15 μg Zitrolid disk. Interpretation involves the correlation of the diameter obtained in the disk test with the MIC for Zitrolid.
Reports from the laboratory providing results of the standard single-disk susceptibility test with a 15 μg Zitrolid disk should be interpreted according to the following criteria:
Interpretation should be as stated above for results using dilution techniques.
As with standardized dilution techniques, diffusion methods require the use of laboratory control microorganisms. The 15 μg Zitrolid disk should provide the following zone diameters in these laboratory test quality control strains:
This medication contains Zitrolid. Do not take Zithromax or Zmax if you are allergic to Zitrolid or any ingredients contained in this drug.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately.
Serious allergic reactions, including angioedema, anaphylaxis, and dermatologic reactions including Stevens-Johnson Syndrome, toxic epidermal necrolysis, and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) have been reported rarely in patients on Zitrolid therapy.
Fatalities have been reported. Despite initially successful symptomatic treatment of the allergic symptoms, when symptomatic therapy was discontinued, the allergic symptoms recurred soon thereafter in some patients without further Zitrolid exposure. These patients required prolonged periods of observation and symptomatic treatment. The relationship of these episodes to the long tissue half-life of Zitrolid and subsequent prolonged exposure to antigen is presently unknown.
If an allergic reaction occurs, the drug should be discontinued and appropriate therapy should be instituted. Physicians should be aware that allergic symptoms may reappear when symptomatic therapy is discontinued.